Skip to main content
. Author manuscript; available in PMC: 2022 Jan 14.
Published in final edited form as: Mov Disord. 2014 Feb 14;29(4):532–538. doi: 10.1002/mds.25816

Table 1.

Patient characteristics (N=54)

Baseline patient characteristics
Male/Female 34/20
Age mean ± SD (range) 58.8 ± 6.3 (42 to 69)
Disease duration mean ± SD (range) 12.5 ± 4.7 (6 to 25)
Levodopa equivalent daily dose (LEDD) (mg/day) 1556 ± 671

UPDRS-III off medication 48.1 ± 17.9 range 20–89
UPDRS-III on-medication 12.4 ± 7.8 range 2–31